The launch of Pixxoscan expands GE HealthCare’s portfolio of Magnetic Resonance Imaging (MRI) contrast agents, now offering two leading macrocyclic molecules to customers - Clariscan (gadoteric acid) ...
(RTTNews) - GE HealthCare (GEHC) announced the submission of its next-generation SIGNA™ MRI technology to the U.S. Food and Drug Administration (FDA) for 510(k) clearance. The new systems are designed ...
CHICAGO--(BUSINESS WIRE)-- GE HealthCare (Nasdaq: GEHC) today announced the 510(k) submissions to the U.S. Food and Drug Administration (FDA) seeking clearance for next-generation SIGNA™ MRI ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min GE HealthCare’s Waukesha-based ...
SAN DIEGO--(BUSINESS WIRE)--GE HealthCare today announced a collaboration with the University of California San Diego School of Medicine to investigate advanced magnetic resonance imaging (MRI) ...
The anticipated acquisition aligns with GE HealthCare’s precision care strategy with the goal of strengthening the company’s portfolio of offerings in neurological care and its quantitative analysis ...
Artificial intelligence once again took the spotlight at the annual meeting of the Radiological Society of North America, where the biggest names in digital imaging demonstrated their cutting-edge ...
Gift Article 10 Remaining As a subscriber, you have 10 articles to gift each month. Gifting allows recipients to access the article for free. GE HealthCare Technologies Inc. signed a seven-year ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback